Chase AIPricingFAQs
Display currency
Loading news…

AYUMI Pharmaceutical

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Tokyo, Japan Founded 2015 251-500 employees For Profit

AYUMI Pharmaceutical is a specialty pharmaceutical company manufactures and sells a portfolio of drug products.

AYUMI Pharmaceutical was acquired by GNI Group in 2026 for $280.05M.
Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
1
Patents
14
5 trademarks

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
20
Patents granted
14
Trademarks
5
Top patent class
Medical Or Veterinary Science; Hygiene

Company Info

Founded
2015
Employees
251-500
Operating status
Active
Company type
For Profit
Org types
company
News articles
6
HQ
Tokyo, Japan
Region
Asia-Pacific (APAC)
Exit date
Jun 8, 2026

Signals & Scores

Heat score
High
Growth score
High
Trend (7d)
-0.4
Trend (30d)
-0.7
Trend (90d)
9.2
1
professional contacts at AYUMI Pharmaceutical
Contact execs at AYUMI Pharmaceutical

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to AYUMI Pharmaceutical

Loading news…

FAQs about AYUMI Pharmaceutical

People who checked this page also checked these

Browse the full Acquirezy directory.
AYUMI Pharmaceutical - Company Profile, Full Acquisitions List, Funding and Investments